SCHEMBL124451

SCHEMBL124451

O=NC(=O)C(=O)O.[NaH]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL134451 0.96
SCHEMBL10284981 0.74
SCHEMBL7596132 0.74
Oxalic Acid SCHEMBL7762360 0.67 CA1 (0.55)
SCHEMBL2479977 0.67 LDHA (0.33)
SCHEMBL27361 0.65
Oxalic Acid SCHEMBL615792 0.63
Oxalic Acid SCHEMBL29256913 0.63 CA1 (0.50)
Oxalic Acid SCHEMBL6313658 0.63
Oxalic Acid SCHEMBL28414861 0.63 CA1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904033-B1 METHOD FOR PRODUCING PHARMACEUTICAL COMPOSITIONS CONTAINING GLIMEPIRIDE ALFRED E TIEFENBACHER GMBH & C (DE) 2009-09-09 EP claimed
EP-1407766-B1 Pharmaceutical compositions that contain a salt of alendronic acid VERISFIELD UK LTD (GR) 2009-07-01 EP claimed
EP-1628648-B1 DERAMCICLANE-FUMARATE TABLETS EGIS GYOGYSZERGYAR NYRT (HU) 2007-12-19 EP claimed
EP-1432406-B1 PHARMACEUTICAL COMPOSITION COMPRISING A WATER/OIL/WATER DOUBLE MICROEMULSION INCORPORATED IN A SOLID SUPPORT GEOTECH PHARMA INC (CA) 2007-04-18 EP claimed
EP-0381218-B1 EXTENDED RELEASE GEMFIBROZIL COMPOSITION WARNER-LAMBERT COMPANY (US) 1993-05-05 EP claimed
EP-4096428-B1 VETERINARY ANTI-PROLACTIN COMPOSITION FOR RUMINANTS USED BY INTRAMAMMARY ADMINISTRATION CEVA SANTE ANIMALE (FR) 2023-10-11 EP disclosed
WO-2023144289-A1 USE OF A MIXTURE OF FLAVANOLS TO INCREASE THE CONCENTRATION OF THE ACTIVE FORM OF VITAMIN D, CALCITRIOL ACTIV'INSIDE (FR) 2023-08-03 WO disclosed
US-20230063100-A1 VETERINARY ANTI-PROLACTIN COMPOSITION FOR RUMINANTS USED BY INTRAMAMMARY ADMINISTRATION CEVA SANTE ANIMALE (FR) 2023-03-02 US disclosed
EP-4096428-A1 VETERINARY ANTI-PROLACTIN COMPOSITION FOR RUMINANTS USED BY INTRAMAMMARY ADMINISTRATION Ceva Santé Animale (FR) 2022-12-07 EP disclosed
WO-2021151897-A1 VETERINARY ANTI-PROLACTIN COMPOSITION FOR RUMINANTS USED BY INTRAMAMMARY ADMINISTRATION CEVA SANTE ANIMALE (FR) 2021-08-05 WO disclosed
EP-3582767-B1 PHARMACEUTICAL ACTIVE INGREDIENT AND USE THEREOF, IN PARTICULAR FOR THE PREVENTION AND TREATMENT OF METABOLIC DISORDERS IN HUMANS AND ANIMALS VALBIOTIS (FR) 2021-04-07 EP disclosed
WO-2018149812-A1 PHARMACEUTICAL ACTIVE INGREDIENT AND USE THEREOF, IN PARTICULAR FOR THE PREVENTION AND TREATMENT OF METABOLIC DISORDERS IN HUMANS AND ANIMALS VALBIOTIS (FR) 2018-08-23 WO disclosed
US-20140024670-A1 VETERINARY ANTI-PROLACTIN COMPOSITION FOR RUMINANTS CEVA SANTE ANIMALE (FR) 2014-01-23 US disclosed
EP-2214632-B1 LIGHTENING AND/OR DYEING OF HUMAN KERATIN FIBRES BY MEANS OF A COMPOSITION COMPRISING A PARTICULAR AMINO SILICON COMPOUND OREAL (FR) 2012-03-07 EP disclosed
EP-2167046-B1 PHARMACEUTICAL SOLID PREPARATION COMPRISING BENZAZEPINES AND PRODUCTION METHOD THEREOF OTSUKA PHARMA CO LTD (JP) 2010-12-01 EP disclosed
EP-2167046-A2 PHARMACEUTICAL SOLID PREPARATION COMPRISING BENZAZEPINES AND PRODUCTION METHOD THEREOF OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-03-31 EP disclosed
WO-2008156217-A3 PHARMACEUTICAL SOLID PREPARATION COMPRISING BENZAZEPINES AND PRODUCTION METHOD THEREOF OTSUKA PHARMA CO LTD (JP) 2009-02-26 WO disclosed
WO-2008156217-A2 PHARMACEUTICAL SOLID PREPARATION COMPRISING BENZAZEPINES AND PRODUCTION METHOD THEREOF OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-12-24 WO disclosed